Incannex Healthcare Inc
IXHL0.365USD
-0.012-3.11%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
70.97MCap. mercado
PérdidaP/E TTM
Más Datos de Incannex Healthcare Inc Compañía
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
Información de Incannex Healthcare Inc
Símbolo de cotizaciónIXHL
Nombre de la empresaIncannex Healthcare Inc
Fecha de salida a bolsaMar 18, 2022
Director ejecutivoMr. Joel Latham
Número de empleados9
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 18
Dirección8 Century Circuit
Ciudad
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísAustralia
Código postal2153
Teléfono61409840786
Sitio Web
Símbolo de cotizaciónIXHL
Fecha de salida a bolsaMar 18, 2022
Director ejecutivoMr. Joel Latham
Ejecutivos de Incannex Healthcare Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.58M
+26.96%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
769.72K
+3.36%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
639.55K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
270.85K
+10.17%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
17.93K
--
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Luigi M. (Lou) Barbato, M.D.
Dr. Luigi M. (Lou) Barbato, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Robert B. Clark
Mr. Robert B. Clark
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.58M
+26.96%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
769.72K
+3.36%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
639.55K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
270.85K
+10.17%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
17.93K
--
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Desglose de ingresos
FY2025Q1
FY2024
FY2024Q4
FY2022
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Australia
74.00K
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Latham (Joel)
0.45%
Valentine (Troy Robert)
0.30%
Anastassov (George)
0.22%
Changoer (Lekhram)
0.18%
AdvisorShares Investments, LLC
0.14%
Otro
98.71%
Accionistas
Accionistas
Proporción
Latham (Joel)
0.45%
Valentine (Troy Robert)
0.30%
Anastassov (George)
0.22%
Changoer (Lekhram)
0.18%
AdvisorShares Investments, LLC
0.14%
Otro
98.71%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
1.28%
Corporation
1.11%
Investment Advisor
0.27%
Investment Advisor/Hedge Fund
0.03%
Research Firm
0.02%
Otro
97.28%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
38
3.08M
0.89%
+1.73M
2025Q2
39
10.29M
34.95%
+3.27M
2025Q1
36
6.86M
34.69%
+1.54M
2024Q4
34
5.22M
29.25%
-10.87K
2024Q3
35
5.23M
32.43%
+928.92K
2024Q2
32
5.32M
33.29%
+935.04K
2024Q1
33
4.38M
27.39%
+2.50M
2023Q4
26
4.32M
27.01%
+2.81M
2023Q3
13
32.37K
0.05%
-34.33K
2023Q2
11
12.21K
0.02%
-63.09K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Latham (Joel)
1.24M
0.36%
-335.00K
-21.24%
Apr 09, 2025
Valentine (Troy Robert)
869.01K
0.25%
-167.50K
-16.16%
Apr 09, 2025
Anastassov (George)
744.72K
0.21%
-25.00K
-3.25%
Apr 09, 2025
Changoer (Lekhram)
639.55K
0.18%
--
--
Apr 09, 2025
AdvisorShares Investments, LLC
343.95K
0.1%
+48.92K
+16.58%
Jun 30, 2025
LPL Financial LLC
323.90K
0.09%
+323.90K
--
Jun 30, 2025
Widdows (Peter)
245.85K
0.07%
-25.00K
-9.23%
Apr 09, 2025
Geode Capital Management, L.L.C.
116.35K
0.03%
--
--
Aug 31, 2025
Commonwealth Financial Network
55.27K
0.02%
+55.27K
--
Jun 30, 2025
Clark (Robert)
75.00K
0.02%
-25.00K
-25.00%
Apr 09, 2025
Ver más
ETFs relacionados
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
AdvisorShares Psychedelics ETF
1.59%
Amplify Alternative Harvest ETF
0%
AdvisorShares Psychedelics ETF
Proporción1.59%
Amplify Alternative Harvest ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
